SEC Form 4 · accession 0001144204-15-000238
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martyn D Greenacre
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 2, 2015 · 9:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Jan 2, 2015 | A | 14,000 | $0.00 | A | 78,531 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 2, 2015 (the "Grant Date"), the Reporting Person was granted an award of 14,000 shares of the Issuer's common stock, $.001 par value, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan. The grant was made pursuant to the Issuer's Director Compensation Plan. This award was fully vested on the Grant Date.